NCT02318771
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +39 more
- Locations
-
- Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States
Clinical trial condition
Recurrent Lung Carcinoma
Explore clinical trials studying Recurrent Lung Carcinoma. Study availability and eligibility vary by location and protocol.
5 public trials
0 recruiting studies
Recurrent Lung Carcinoma trial results
NCT01638533
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +125 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
NCT04662645
- Conditions
- Caregiver, Hemic and Lymphatic Diseases, Lung Diseases, +22 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Completed
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
NCT01522820
- Conditions
- Adenocarcinoma, Adnexal Diseases, Anaplastic Astrocytoma, +137 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Active, Not Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
NCT02465060
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Lymphoma, +138 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Thomas Hospital Fairhope, Alabama, United States
- Mobile Infirmary Medical Center Mobile, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States